Cite
HARVARD Citation
Kumar, A. et al. (n.d.). Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial. Diabetes & vascular disease research. pp. 171-177. [Online].